Nuts and bolts of COVID-19 associated coagulopathy: the essentials for management and treatment.
Postgrad Med
; 133(8): 899-911, 2021 Nov.
Article
in English
| MEDLINE | ID: covidwho-1390265
ABSTRACT
INTRODUCTION:
COVID-19-associated coagulopathy (CAC) is a well-recognized hematologic complication among patients with severe COVID-19 disease, where macro- and micro-thrombosis can lead to multiorgan injury and failure. Major societal guidelines that have published on the management of CAC are based on consensus of expert opinion, with the current evidence available. As a result of limited studies, there are many clinical scenarios that are yet to be addressed, with expert opinion varying on a number of important clinical issues regarding CAC management.METHODS:
In this review, we utilize current societal guidelines to provide a framework for practitioners in managing their patients with CAC. We have also provided three clinical scenarios that implement important principles of anticoagulation in patients with COVID-19.CONCLUSION:
Overall, decisions should be made on acase by cases basis and based on the providers understanding of each patient's medical history, clinical course and perceived risk.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Thromboembolism
/
Thrombosis
/
Blood Coagulation Disorders
/
Practice Guidelines as Topic
/
COVID-19
/
Anticoagulants
Type of study:
Diagnostic study
/
Observational study
/
Prognostic study
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
Postgrad Med
Year:
2021
Document Type:
Article
Affiliation country:
00325481.2021.1974212
Similar
MEDLINE
...
LILACS
LIS